Iovance Biotherapeutics
Kerry Elizabeth Wilson, Esq. currently serves as Executive Counsel at Iovance Biotherapeutics, Inc. since May 2022. Prior to this role, Kerry was Associate General Counsel at The Wistar Institute from August 2018 to April 2022, providing legal guidance on various matters including intellectual property, compliance, and contractual negotiations. Kerry's experience also includes serving as Senior Associate Director at the University of Pennsylvania, where negotiations for sponsored research agreements were a primary responsibility. Earlier career roles include positions at Drexel University, Philadelphia Health Management Corporation, and the City of Philadelphia. Kerry holds a BA from Temple University and a JD from the James E. Beasley School of Law at Temple University.
This person is not in any teams
This person is not in any offices
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.